Advances in Inpatient Diabetes Care

Dear Colleagues,

The last decade has seen wide advances across the range of diabetes care, from strong evidence of combined glucose, renal and cardiac benefits of sodium glucose co-transporter agents, and for incretins added metabolic effects which have transformed the therapeutic space for Type 2 diabetes to technology radically changing the measurement of blood glucose levels and in Type 1 diabetes, embedding this into devices that use real-time blood glucose measures to minutely regulate insulin release. Collectively, these have significantly improved the lived experience of people with diabetes mellitus.

However, when this same period is looked through the lenses of demography and public health, it is marked by an increasing prevalence of the condition, especially Type 2 diabetes, and increasing numbers of people with diabetes needing access to acute hospital care; despite these advances, those with diabetes are hospitalised and have poorer outcomes than those without diabetes.

This Special Issue, titled “Advances in Inpatient Diabetes Care”, is an excellent opportunity to consider by how much and to what degree the advances in clinical and therapeutics for diabetes impact care in the hospital, how technology provides different ways of managing blood glucose levels, how clinical practice guidelines, including those for hyperglycaemic emergencies, operate at the ward level, and how inpatient-related diabetes care transitions through to discharge and beyond. We welcome original research, review articles, and forward-looking perspectives that address these critical facets of hospital-based diabetes care.

Dr. Namson Lau
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.